Skip to content
Nonprofiteer
← GLAUCOMA FOUNDATION INC

Form 990 for tax year 2025

Filed by GLAUCOMA FOUNDATION INC.

Totals

Total revenue
$5,962,992
Total expenses
$3,058,551
Contributions and grants received
$5,045,092
Grants paid
$982,807
Program service revenue
$0
Investment income
$917,900
Other revenue
$0
Total assets, end of year
$20,750,332
Total liabilities, end of year
$1,458,790
Net assets or fund balances, end of year
$19,291,542
Program services expenses (Part IX)
$2,374,931
Management and general expenses
$338,961
Fundraising expenses
$344,659
Program service expenses (Part III)
$2,374,931

Program services were 77.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1c · Fundraising events

    $269,651

  • 1f · All other contributions, gifts and grants

    $4,775,441

  • 1g · Noncash contributions included above

    $270,323

  • 3 · Investment income

    total $390,113 · excluded $390,113

  • 7a · Gross sales of assets other than inventory

    securities $1,904,823

  • 7b · Less cost or other basis and sales expenses

    securities $1,377,036

  • 7c · Gain or loss

    securities $527,787

  • 7d · Net gain or loss

    total $527,787 · excluded $527,787

  • 8a · Fundraising events: gross income

    $110,128

  • 8a · Fundraising events: contributions included on line 1c

    $269,651

  • 8b · Fundraising events: direct expenses

    $110,128

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $700,700 · program services $700,700

  • 3 · Grants to foreign organizations and individuals

    total $282,107 · program services $282,107

  • 5 · Compensation of officers, directors and key employees

    total $421,778 · program services $295,244 · management and general $21,091 · fundraising $105,443

  • 7 · Other salaries and wages

    total $396,084 · program services $312,701 · management and general $28,503 · fundraising $54,880

  • 8 · Pension plan contributions

    total $22,223 · program services $16,519 · management and general $1,347 · fundraising $4,357

  • 9 · Other employee benefits

    total $86,390 · program services $64,215 · management and general $5,239 · fundraising $16,936

  • 10 · Payroll taxes

    total $51,160 · program services $38,030 · management and general $3,102 · fundraising $10,028

  • 11e · Fees: professional fundraising services

    total $17,250 · fundraising $17,250

  • 11f · Fees: investment management

    total $157,443 · management and general $157,443

  • 11g · Fees: other

    total $150,250 · program services $14,073 · management and general $114,274 · fundraising $21,903

  • 13 · Office expenses

    total $55,303 · program services $41,108 · management and general $3,354 · fundraising $10,841

  • 16 · Occupancy

    total $67,586 · program services $50,239 · management and general $4,098 · fundraising $13,249

  • 17 · Travel

    total $14,175 · program services $14,175

  • 19 · Conferences, conventions and meetings

    total $153,126 · program services $153,126

  • 22 · Depreciation, depletion and amortization

    total $1,048 · program services $778 · management and general $64 · fundraising $206

  • 23 · Insurance

    total $7,360 · program services $5,471 · management and general $446 · fundraising $1,443

  • 24a · Other expenses: DIRECT MAIL

    total $193,408 · program services $157,993 · fundraising $35,415

  • 24b · Other expenses: COMMUNITY OUTREACH

    total $161,111 · program services $161,111

  • 24c · Other expenses: POSTAGE AND SHIPPING

    total $89,788 · program services $67,341 · fundraising $22,447

  • 24d · Other expenses: FUNDRAISING FEES

    total $23,350 · fundraising $23,350

  • 24e · All other expenses

    total $6,911 · fundraising $6,911

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $1,515,978 · end of year $659,461

  • 2 · Savings and temporary cash investments

    beginning of year $4,925,602 · end of year $6,537,970

  • 3 · Pledges and grants receivable

    beginning of year $375,000 · end of year $1,650,000

  • 9 · Prepaid expenses and deferred charges

    beginning of year $91,660 · end of year $67,001

  • 10a · Land, buildings and equipment: cost or other basis

    $102,357

  • 10b · Land, buildings and equipment: accumulated depreciation

    $98,384

  • 10c · Land, buildings and equipment, net

    beginning of year $3,813 · end of year $3,973

  • 11 · Investments: publicly traded securities

    beginning of year $9,709,581 · end of year $10,843,751

  • 12 · Investments: other securities

    beginning of year $148,417 · end of year $196,150

  • 15 · Other assets

    beginning of year $815,127 · end of year $792,026

  • 17 · Accounts payable and accrued expenses

    beginning of year $163,444 · end of year $159,088

  • 18 · Grants payable

    beginning of year $412,210 · end of year $426,404

  • 19 · Deferred revenue

    beginning of year $40,000 · end of year $109,068

  • 25 · Other liabilities

    beginning of year $787,331 · end of year $764,230

  • 27 · Net assets without donor restrictions

    beginning of year $9,806,400 · end of year $10,750,550

  • 28 · Net assets with donor restrictions

    beginning of year $6,375,793 · end of year $8,540,992

Mission and programs · 2025

Mission

THE GLAUCOMA FOUNDATION, INC. IS AN INTERNATIONAL NOT-FOR-PROFIT ORGANIZATION DEDICATED TO ERADICATING GLAUCOMA, THE LEADING CAUSE OF PREVENTABLE BLINDNESS. THE STRATEGY TO ACHIEVE THIS GOAL IS TWO-FOLD: RAISE PUBLIC AWARENESS CONCERNING THE NECESSITY OF ROUTINE EYE EXAMS, AND FUND CRITICAL RESEARCH TO FIND CURES FOR GLAUCOMA.

Activities or mission (Part I)

THE GLAUCOMA FOUNDATION, INC. IS AN INTERNATIONAL NOT-FOR-PROFIT ORGANIZATION DEDICATED TO ERADICATING GLAUCOMA.

  • 1) MULTIPLE WEBINARS: WHAT DO COLD HANDS HAVE TO DO WITH GLAUCOMA? THE PROMISE OF OPTIC NERVE REGENERATION; THE BODY-EYE RELATIONSHIP HOW TO SAVE THE SIGHT OF PATIENTS WITH GLAUCOMA WHILE MINIMIZING ADVERSE REACTION FROM EYE DROPS; INSIGHTS INTO GLAUCOMA & WOMEN'S HEALTH: EXPLORING THE IMPACT OF MENOPAUSE AND VISUAL FUNCTION; GLAUCOMA AND LIFESTYLE. 2) THE OPTIC NERVE RESCUE AND RESTORATION THINK TANK "A PATIENT-CENTRIC APPROACH WHILE INCORPORATING THE LATEST SCIENCE" GLAUCOMA DATA INTEGRATION: OVERVIEW OF DATABASES AVAILABLE TO ADVANCE GLAUCOMA KNOWLEDGE; LESSONS LEARNED ABOUT GLAUCOMA FROM THE UK BIOBANK; POAG GENOMIC ARCHITECTURE; A 360-DEGREE BIOMEDICAL PROFILE OF HEALTH: LESSONS FROM CARDIOVASCULAR DISEASE. 3) DRUG RE-PURPOSING IN GLAUCOMA: INSULIN SIGNALING AND; METFORMIN AND GLAUCOMA; GLP-1R AGONISTS AND GLAUCOMA. 4) OVERVIEW OF GLAUCOMA NEUROPROTECTION AGENTS: WHY DO WE NOT HAVE A NEUROPROTECTION AGENT FOR GLAUCOMA? HOW CAN AI HELP FACILITATE RANDOMIZED CLINICAL TRIALS IN NEUROPROTECTION? 5) SEX HORMONES AND GLAUCOMA: THE ROLE OF SEX HORMONES IN THE PATHOGENESIS OF OPEN-ANGLE GLAUCOMA: EVIDENCE FROM EPIDEMIOLOGICAL STUDIES; ESTROGEN SIGNALING PATHWAYS IN GLAUCOMA; THE BIOMECHANICAL ARGUMENT THAT ESTROGEN PLAYS A ROLE IN GLAUCOMA; 6) NON-IOP FACTORS OF IMPORTANCE IN GLAUCOMA: DIET AND GLAUCOMA; HYPERTENSION, ANTIHYPERTENSIVE DRUGS AND GLAUCOMA; THE IMPACT OF GLAUCOMA ON ACTIVITIES OF DAILY LIVING. 7) WHAT CAN TGF DO TO HELP PATIENTS, RESEARCHERS, AND EYECARE PROVIDERS TACKLE GLAUCOMA?: WHAT IS THE GLAUCOMA FOUNDATION DOING NOW? WHAT DO PATIENTS WANT TO SEE IN GLAUCOMA RESEARCH? 8) START WITH THE YOUNG: INFO SESSION ON GLAUCOMA FOR MIDDLE AND HIGH SCHOOL STUDENTS; IN COORDINATION WITH THE STEM INSTITUTE AT THE CITY COLLEGE OF NEW YORK. 9) NEWSLETTERS: TGF PRODUCED SIX ELECTRONIC NEWSLETTERS THAT WERE DISTRIBUTED TO MORE THAN 16,000 HOUSEHOLDS. TGF'S QUARTERLY PRINTED NEWSLETTERS WERE AVAILABLE FOR CONSTITUENTS WHO DO NOT USE COMPUTERS OR WHO PREFER TO READ PAPER DOCUMENTS. NEWSLETTERS INCLUDE INTERVIEWS WITH DOCTORS, RESEARCHERS, AND PATIENTS. THEY COVER TOPICS SUCH AS ADVANCEMENTS IN DIAGNOSIS AND TREATMENT, PERSPECTIVES ON CARE, AND PERSONAL STORIES OF LIVING WITH THE DISEASE.

    Expenses $865,695

  • 1) GENETIC PREDISPOSITION AND OPHTHALMIC OUTCOMES; 2) OPTIC NERVE REGENERATION; 3) USING ARTIFICIAL INTELLIGENCE TO REVEAL BLOOD PRESSURE'S ROLE IN GLAUCOMA PROGRESSION; 4) EE-PURPOSING AN "OLD" DRUG FOR A NEW INDICATION: ELUCIDATING THE PERIPHERAL AND CENTRAL EFFECTS OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS TO TREAT GLAUCOMA; 5) SEARCH FOR FUNCTIONAL LOXL1 RISK ALLELES WITH BIT-STARR; 6) VASCULAR GENOTYPE-PHENOTYPE ASSOCIATION IN PRIMARY OPEN-ANGLE GLAUCOMA; 7) INVESTIGATING THE ROLE OF IMPAIRED MITOCHONDRIAL DYNAMICS IN EXFOLIATION GLAUCOMA; 8) UNCOVERING THE POTENTIAL OF PERICYTES AS THERAPEUTIC TARGETS FOR GLAUCOMA; 9) NICOTINAMIDE AND PYRUVATE FOR NEUROENHANCEMENT IN OPEN-ANGLE GLAUCOMA: A PHASE 2 RANDOMIZED CLINICAL TRIAL.

    Expenses $1,509,236 · Grants $982,807

As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Elena Sturman

    PRESIDENT &

    Total calculated
    $444,333
    From this org
    $421,776
    From related orgs
    $0
    Other
    $22,557
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $421,776
    Bonus
    not reported
    Other
    not reported
    Deferred
    $22,557
    Nontaxable benefits
    not reported
    Filer's total
    $444,333

  • Elena Cly Fowkes

    DIR OF SPECI

    Total calculated
    $166,491
    From this org
    $143,934
    From related orgs
    $0
    Other
    $22,557
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $143,934
    Bonus
    not reported
    Other
    not reported
    Deferred
    $22,557
    Nontaxable benefits
    not reported
    Filer's total
    $166,491

  • Andrea Steele

    CHIEF OPERAT

    Total calculated
    $143,035
    From this org
    $120,294
    From related orgs
    $0
    Other
    $22,741
    Hours/week
    40

  • Gregory K Harmon

    CHAIRMAN

    Total calculated
    $0
    Hours/week
    1

  • Kenneth Mortenson

    CHAIR. INV.

    Total calculated
    $0
    Hours/week
    1

  • Baldo Scassellati Sforzolini

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • John Berdahl

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Reza Dibadj

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Murray Fingeret

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • David Fellows

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Barry S Friedberg

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Jeffrey M Liebmann

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Kumar Mahadeva

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Jai G Parekh

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Patricia Hill

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Joe Rosen

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Louis Pasquale

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Sheldon M Siegel

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Barbara Calaba

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Carole Darden-Lloyd

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Alon Harris

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Annette Grollman

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Rajen Savjani

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Barbara Hearst

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Mitch Hill

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Form 990 of other organizations
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Provenance

Return type
form_990
Tax year
2025
Filed
27 April 2026
IRS schema version
2025v4.0
Source object
202601199349301660

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.